The Canada tissue diagnostics market is anticipated to grow at a CAGR 5.6% during the forecast period. Canada has significantly improved the healthcare system on the back of various driving factors such as availability of technologically sound diagnostic centres, adoption of robotic automation and a huge pool of cancer population. According to the Canadian health ministry in 2018 Canada spent $253.5 billion in healthcare and expected to increase due to healthcare reforms and government policies. Almost 70 % of Canadian healthcare cost is paid by the government which is resulting in ease of diagnosis and treatment.
Every citizen and permanent resident is provided a medical insurance plan for a variety of healthcare services.

A full report of Canada Tissue Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/canada-tissue-diagnostics-market

The major factors influencing the Canada tissue diagnostics market include rising adoption of personalized medicine, growth of the IVD market, aging population and rising mortality and incidences of cancer across the region. Canadians are more prone to lung cancer than other regions, according to the Canada Cancer Society the incidence of cancer in Canadians is 58 and 48 in 0.1 million cancer patients in male and female patients respectively in Canada.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/canada-tissue-diagnostics-market

Moreover, the rising incidence and prevalence of cancer diseases across Canada created a huge demand for instruments, reagents and digital pathology systems that are used in clinical histology, cytology, and drug discovery laboratories. The Canada tissue diagnostic market is expected to grow significantly due to the rising cancer care and support of government and private players. Major players those are active in the market that includes Abbott Laboratories, Inc., Agilent Technologies, Biogenex Laboratories, Cell Signaling Technology, Inc., Bio SB, Danaher Corporation, Life Technologies, Thermo Fisher Scientific, Inc and Sigma-Aldrich.

Canada Tissue Diagnostics Market – Segmentation

by Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology and Workflow Management
• Special Staining
• Hematoxylin & Eosin (H&E) Stain

by Diseases

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Carcinoma

by Product

• Instruments
• Consumables

by End-User

• Hospitals
• Pharmaceuticals
• Research Institute
• Laboratories
• Other Research

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/canada-tissue-diagnostics-market

Company Profiles

• Alere, Inc.
• Becton, Dickinson and Co.,
• Bio SB
• Biogenex Laboratories
• BioMérieux SA
• Cell Signalling Technology, INC.
• DiaGenic ASA
• Prometheus Laboratories
• QIAGEN AG
• Stryker Corp.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404